Literature DB >> 34463575

Adenovirus Remodeling of the Host Proteome and Host Factors Associated with Viral Genomes.

Joseph M Dybas1,2,3, Krystal K Lum1,2, Katarzyna Kulej1,2, Emigdio D Reyes1,2, Richard Lauman4,5, Matthew Charman1,2, Caitlin E Purman1,2, Robert T Steinbock2, Nicholas Grams2, Alexander M Price1,2, Lydia Mendoza2, Benjamin A Garcia4,5, Matthew D Weitzman1,2,5.   

Abstract

Viral infections are associated with extensive remodeling of the cellular proteome. Viruses encode gene products that manipulate host proteins to redirect cellular processes or subvert antiviral immune responses. Adenovirus (AdV) encodes proteins from the early E4 region which are necessary for productive infection. Some cellular antiviral proteins are known to be targeted by AdV E4 gene products, resulting in their degradation or mislocalization. However, the full repertoire of host proteome changes induced by viral E4 proteins has not been defined. To identify cellular proteins and processes manipulated by viral products, we developed a global, unbiased proteomics approach to analyze changes to the host proteome during infection with adenovirus serotype 5 (Ad5) virus. We used whole-cell proteomics to measure total protein abundances in the proteome during Ad5 infection. Since host antiviral proteins can antagonize viral infection by associating with viral genomes and inhibiting essential viral processes, we used Isolation of Proteins on Nascent DNA (iPOND) proteomics to identify proteins associated with viral genomes during infection with wild-type Ad5 or an E4 mutant virus. By integrating these proteomics data sets, we identified cellular factors that are degraded in an E4-dependent manner or are associated with the viral genome in the absence of E4 proteins. We further show that some identified proteins exert inhibitory effects on Ad5 infection. Our systems-level analysis reveals cellular processes that are manipulated during Ad5 infection and points to host factors counteracted by early viral proteins as they remodel the host proteome to promote efficient infection. IMPORTANCE Viral infections induce myriad changes to the host cell proteome. As viruses harness cellular processes and counteract host defenses, they impact abundance, post-translational modifications, interactions, or localization of cellular proteins. Elucidating the dynamic changes to the cellular proteome during viral replication is integral to understanding how virus-host interactions influence the outcome of infection. Adenovirus encodes early gene products from the E4 genomic region that are known to alter host response pathways and promote replication, but the full extent of proteome modifications they mediate is not known. We used an integrated proteomics approach to quantitate protein abundance and protein associations with viral DNA during virus infection. Systems-level analysis identifies cellular proteins and processes impacted in an E4-dependent manner, suggesting ways that adenovirus counteracts potentially inhibitory host defenses. This study provides a global view of adenovirus-mediated proteome remodeling, which can serve as a model to investigate virus-host interactions of DNA viruses.

Entities:  

Keywords:  adenovirus; iPOND; mass spectrometry; protein-DNA binding; proteomics; ubiquitin; virus-host interactions

Year:  2021        PMID: 34463575     DOI: 10.1128/mSystems.00468-21

Source DB:  PubMed          Journal:  mSystems        ISSN: 2379-5077            Impact factor:   6.496


  2 in total

1.  Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments.

Authors:  Stephanie Pei Tung Yiu; Rui Guo; Cassie Zerbe; Michael P Weekes; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.423

2.  Novel viral splicing events and open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts.

Authors:  Alexander M Price; Robert T Steinbock; Richard Lauman; Matthew Charman; Katharina E Hayer; Namrata Kumar; Edwin Halko; Krystal K Lum; Monica Wei; Angus C Wilson; Benjamin A Garcia; Daniel P Depledge; Matthew D Weitzman
Journal:  PLoS Pathog       Date:  2022-09-12       Impact factor: 7.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.